News Daily News Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly December 30, 2013
Presentation Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly Presenter: T.W. Yeh December 12, 2013
News Conference News TCT 2013 Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit November 03, 2013
Presentation TCT 2013 Indigenous Stents: New Technologies and Clinical Data Presenter: Sreenivas Kumar October 31, 2013
Presentation TCT 2013 DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents Presenter: Clemens von Birgelen October 31, 2013
Presentation TCT 2013 Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis Presenter: J?rg Schr?der October 31, 2013
Presentation TCT 2013 RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis Presenter: Fernando Alfonso October 30, 2013
News Conference News TCT 2013 PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years October 30, 2013
Presentation TCT 2013 TCT-18. Clinical and Procedural Predictors and Consequences of Stent Thrombosis Following Drug-eluting Stents for Acute Coronary Syndromes: Results From the ADAPT-DES Study Presenter: Ankit Garg October 29, 2013
Presentation TCT 2013 TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents Presenter: Peter Smits October 29, 2013
Presentation TCT 2013 Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 4-Year Results from the BioFreedom First-In-Man Trial Presenter: 208788|Ricardo Costa October 29, 2013
Presentation TCT 2013 TCT-16. Incidence, mechanisms and outcome of longitudinal stent deformation (LSD) associated with Element, Resolute, Biomatrix and Xience stents: angiographic and case-by-case... Presenter: Samer Arnous October 29, 2013
Presentation TCT 2013 TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents Presenter: Michael Maeng October 29, 2013
Presentation TCT 2013 SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary... Presenter: Bent Raungaard October 29, 2013
Presentation TCT 2013 PROTECT: Four-Year Results from a Prospective, Randomized Trial of Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents Presenter: Laura Mauri October 28, 2013
Presentation TCT 2013 Synthesis of the ISAR Clinical Trials Comparing Different Stents in Different Settings Presenter: Adnan Kastrati October 28, 2013
Presentation TCT 2013 SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona... Presenter: David Cohen October 28, 2013
Presentation TCT 2013 A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon Plus Bare Metal Stents vs. Paclitaxel-Eluting Stents for De Novo Coronary Lesions Presenter: Piotr Buszman October 28, 2013
News Conference News TCT 2013 COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI October 28, 2013
Presentation TCT 2013 Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications Presenter: Sahil Parikh October 27, 2013